TO
1 - 25 of 4
| Creator | Title | Description | Subject | Date | ||
|---|---|---|---|---|---|---|
| 1 |
 |
Waller, Rosalie G. | Exome sequence comparison of seventy-seven multiple myeloma cases identifies potential risk alleles | Multiple Myeloma (MM) is a heritable cancer of plasma cells with poor prognosis. Although a few genomic risk-loci have been identified for MM, no risk variants have been published that explain MM heritability. We hypothesize MM heritability is due to rare germ-line variants that can be discovered th... | Multiple myeloma -- Genetic aspects; Exomes; Exome sequence; Risk alleles | 2015-05 |
| 2 |
 |
Black, Taylor Madison | Impacts of Tobacco Smoke Exposure and Outlier Body Mass Indices on Pediatric Asthma Outcomes | There are seven million children in the United States impacted by asthma [1]. When assessing the severity of a child's asthma, it is important to take into account risk factors known to affect child hood asthma. Two such risk factors that are modifiable include parental tobacco smoke exposure (TSE)... | Asthma - Child; Tobacco smoke - Health aspects - United States | 2015-05 |
| 3 |
 |
Khoury, Mark | Muscle activity changes due to immobilization and partial weight bearing of the lower leg | Tibial fractures account for half a million hospitalizations per year. Although clinical treatment of tibial fractures requires immobilization of the affected limb and partial weight bearing (PWB) prescriptions, the effects of this treatment protocol on gait and muscle activity have not been studied... | Muscles -- Physiology; Tibia -- Wounds and injuries; Muscle activity; Partial weight bearing | 2015-05 |
| 4 |
 |
Javdan, Shwan | Targeted HPMA copolymer-gemcitabine conjugates for the treatment of ovarian carcinoma | Each year in the United States, over 14,000 women die from ovarian cancer. Anthracyclines-a class of chemotherapeutics-have long been the primary treatment for this and many other cancers, yet they often leave patients with cardiotoxicity, hepatotoxicity, and a number of other adverse effects. Polym... | Ovaries -- Cancer -- Treatment; Polymeric drug delivery systems; Polymer-drug conjugates; pHPMA | 2015-12 |
1 - 25 of 4